Mid and South Essex NHS Foundation Trust is an NHS foundation trust based in Essex, England. It runs three major hospitals across Essex, and a number of smaller community hospitals. One of the biggest NHS trusts in the country, it serves a population of 1.2 million people and has an annual revenue of over £850m.

During the past decade, Mid and South Essex NHS Foundation Trust conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mid and South Essex NHS Foundation Trust" #1 sponsor was "Imperial College London" with 2 trials, followed by "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "King's College Hospital NHS Trust" with 1 trials sponsored and "Oxurion" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mid and South Essex NHS Foundation Trust" #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator, "King's College London" with 1 trials as a collaborator, "Mid and South Essex NHS Foundation Trust" with 1 trials as a collaborator, "Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust" with 1 trials as a collaborator and "Royal Free Hospital NHS Foundation Trust" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Mid and South Essex NHS Foundation Trust" are "Breast Cancer" (1 trials), "Critical Limb Ischemia" (1 trials), "Critical Lower Limb Ischemia" (1 trials), "Diabetes Mellitus" (1 trials) and "Diabetic Foot" (1 trials). Many other conditions were trialed in "Mid and South Essex NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Mid and South Essex NHS Foundation Trust" are "Drug" (3 trials), "Diagnostic Test" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aflibercept 2mg" (1 trials), "Ankle Brachial Pressure Index (ABPI)" (1 trials), "Audible handheld Doppler" (1 trials), "Axillary lymph node dissection" (1 trials) and "Axillary radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mid and South Essex NHS Foundation Trust" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Mid and South Essex NHS Foundation Trust". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mid and South Essex NHS Foundation Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mid and South Essex NHS Foundation Trust, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Mid and South Essex NHS Foundation Trust has several departments that took part in Clinical trials: "The Essex Cardiothoracic Centre" - 13 trials, "Broomfield Hospital; Oncology" - 5 trials